Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Striate+™

K-Number: K201241 · 2021-01-11

Decision Date2021-01-11
Product CodeNPL
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Striate+™ is a medical device manufactured by Orthocell, Ltd.. It received FDA 510(k) clearance on 2021-01-11 under approval number K201241. The device is classified under product code NPL. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Striate+™?

Striate+™ is a medical device that received FDA 510(k) clearance on 2021-01-11. It is manufactured by Orthocell, Ltd.. The 510(k) number is K201241.

When was Striate+™ approved by the FDA?

Striate+™ received FDA 510(k) clearance on 2021-01-11, under approval number K201241.

What company makes Striate+™?

Striate+™ is manufactured by Orthocell, Ltd..

What is the FDA product code for Striate+™?

The FDA product code for Striate+™ is NPL.

Other Devices by Orthocell, Ltd.

Related Devices (Code: NPL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.